Table of Content - Heparin Market

Heparin is an anticoagulant used to decrease the clotting ability of blood and help to prevent harmful clots from forming in blood vessels. It is sometimes referred as a blood thinner, although it does not actually thin the blood. Heparin does not dissolve already formed blood clots, but it can prevent the clots from becoming larger and causing more serious problems. Pharmaceutical-grade heparin is derived from animal tissue. Heparin is commonly used in the treatment of coronary heart disease, pulmonary embolism, deep vein thrombosis, and atrial fibrillation, and in the prevention of thrombosis during extracorporeal membrane oxygenation and cardiopulmonary bypass.

Market Dynamics

Rising cases of conditions such as coronary heart disease, pulmonary embolism, and deep vein thrombosis is one of the major factors for increased demand of heparin drugs in the market. Myocardial infarction (MI) is one of the major complications of coronary heart disease. According to the American Heart Association 2018 report, coronary heart disease is the leading cause (43.8%) of deaths due to cardiovascular disease in the U.S., followed by stroke (16.8%). As per the Centres for Disease Control and Prevention (CDC) 2015 report, deep vein thrombosis affects nearly 900,000 individuals in the U.S. each year.

Despite major applications in chronic conditions, heparin is poorly absorbed by the intestine, therefore it must be given intravenously or subcutaneously. Moreover, the drug creates a significant risk of excessive bleeding due to anticlotting effect. Heparin also induce conditions such as thrombocytopenia (reduced number of circulating platelets) and hypersensitivity reactions. These factors can hamper the heparin market, during the forecast period.

Key features of the study

This report provides in-depth analysis of the heparin market, market size (USD Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global heparin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Anselm Pharmaceuticals, Baxter International Inc., B. Braun Melsungen AG, Bristol-Myers Squibb Co., Dr. Reddy’s Laboratories Ltd., Fresenius SE & Co. KGaA, Leap Labchem Co., LEO Pharma A/S, Pfizer, Inc., Sanofi S.A., Syntex S.A., Teva Pharmaceutical Industries Ltd., and United Biotech (P) Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global heparin market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for heparin market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

Product Type Insights (Revenue, USD Mn, 2026 - 2033)

Unfractionated Heparin (UH)
Low Molecular Weight Heparin (LMWH)
Ultra-low Molecular Weight Heparin (ULMW)

Dosage Form Insights (Revenue, USD Mn, 2026 - 2033)

Injection
Solutions

Regional Insights (Revenue, USD Mn, 2026 - 2033)

North America

U.S.
Canada

Latin America

Brazil
Argentina
Mexico
Rest of Latin America

Europe

Germany
U.K.
France
Italy
Russia
Rest of Europe

Asia Pacific

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

GCC
Israel
Rest of Middle East

Africa

North Africa
Central Africa
South Africa

Key Players Insights

Anselm Pharmaceuticals
Baxter International Inc.
B. Braun Melsungen AG
Bristol-Myers Squibb Co.
Dr. Reddy’s Laboratories Ltd.
Fresenius SE & Co. KGaA
Leap Labchem Co.
LEO Pharma A/S
Pfizer, Inc.
Sanofi S.A.
Syntex S.A.
Teva Pharmaceutical Industries Ltd.
United Biotech (P) Ltd.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Heparin Market, By Product Type
  - Global Heparin Market, By Dosage Form
  - Global Heparin Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend
Global Heparin Market, By Product Type, 2020-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 - 2033
  - Segment Trends
- Unfractionated Heparin (UH)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
- Low Molecular Weight Heparin (LMWH)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
- Ultra-low Molecular Weight Heparin (ULMW)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Global Heparin Market, By Dosage Form, 2020-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 - 2033
  - Segment Trends
- Injection
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
- Solutions
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Global Heparin Market, By Region, 2020 - 2033, Value (USD Mn)
- Introduction
  - Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
  - Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Anselm Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Baxter International Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- B. Braun Melsungen AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bristol-Myers Squibb Co.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Dr. Reddy’s Laboratories Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Fresenius SE & Co. KGaA
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Leap Labchem Co.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- LEO Pharma A/S
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sanofi S.A.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Syntex S.A.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- United Biotech (P) Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now